Diabetes Information

Benfotiamine - A New Tool In Preventing Diabetic Complications?


Benfotiamine made headlines globally in 2003 when researchers released information about a study that was conducted at The Einstein College of Medicine in New York. The bottom line of this study was that a substance of the allithiamine group of the naturally occurring thiamine-derived compounds had positive effects on neuropathy, retinopathy and nephropathy and heart/circulatory problems in diabetics.

Benfotiamine research has suggested that there are beneficial effects for diabetics and non-diabetics also. These benefits include sciatica, vascular health, general nerve health, lower blood pressure, grant cellular protection, anti-aging, fibromyalgia, prevention of lactic acidosis, and treatment for Alzheimer's disease. Any condition that is the result of a thiamine deficiency will also respond quite well to benfotiamine. Of course, any bodily function that is improved by a therapeutic level of thiamine will certainly be enhanced by benfotiamine, since benfotiamine is perhaps the most effective form of thiamine.

Benfotiamine, a derivative of thiamine (vitamin B1), was an invention of Japanese scientists and there is a U.S. patent on benfotiamine that was entered by the Japanese back in 1962. Japanese benfotiamine is considered the purest source of bulk benfotiamine and is favored by manufacturers globally who insist on the highest quality in their benfotiamine product.

The safety of benfotiamine use has been proven over 12 years of use in Europe for the treatment and prevention of diabetic complications among others. The original Japanese patent on benfotiamine gave information that it is even less toxic than common vitamin B1 (thiamine hydrochloride usually). Orally ingested vitamin B1 has a long history of use as an oral supplement without reported adverse effects. Due to its therapeutic action in some frequently observed clinical syndromes, thiamine hydrochloride has been advised and used over a long period of time. There are no reports of adverse effects of oral thiamine, even at dosages of several hundred milligrams a day (SCOGS, 1978; DHEW, 1979; Marks, 1989).

Benfotiamine has a very good safety record. To date, there has been no reports of any known, negative interactions with any medications. To the contrary, some medications actually can cause a thiamine deficiency in some people and benfotiamine could correct this serious situation.

Many researchers, medical experts, doctors, podiatrists and many medical publishers recommend benfotiamine for neuropathy, retinopathy nephropathy, heart/circulatory complications and B1 deficiencies. Any in depth study on the web will produce physicians, naturopaths, neurologists, optometrists, chiropractors, etc. who have very positive feelings about the effectiveness and potential of benfotiamine in terms of the research done to date on this important tool in the arsenal against neuropathy, retinopathy and beneficial for the heart and circulatory system. We have professional healthcare providers from all of these disciplines which shows the confidence the medical community has in the purity and bioavailability of our benfotiamine product.

Dr. David Williams, publisher of "Alternatives Newsletter", wrote an in depth article concerning benfotiamine in his May, 2004 issue. This article is an eye opener in terms of how effective benfotiamine can be for many health conditions. If possible, it would be beneficial for any interested reader to take a look at this article. For more information about this article you may contact the author below.

Dr Paul Chous is another medical professional who sees the merits of benfotiamine:

"I suspect strongly that benfotiamine will mitigate (or, hopefully, prevent) DRT in humans, but the burden of proof has not yet been met. The case for symptomatic relief of neuropathy symptoms is, of course, more tangible." http://www.emuhealthproducts.com/drchous.html

In conclusion, the consensus for benfotiamine is very positive and are worth investigating. If you or anyone you know is a diabetic, the great possibility of developing diabetic complications over time makes benfotiamine a viable tool in the arsenal for protection. If they are already experiencing complications such as neuropathy, retinopathy, and others, they will benefit from possible reduction in the progression along with pain relief in terms of peripheral neuropathy and other neuropathies.

Zach Malott is CEO of Brentwood Health International, a nutritional supplement company involved in distribution and supplying wholesale, retail and end users.

Mr. Malott is available to discuss the research as it applies to benfotiamine in the treatment and prevention of diabetic complications such as neuropathy and retinopathy.

He can be reached at:

Phone: 505.354.0526

Website: http://www.emuhealthproducts.com


MORE RESOURCES:

Reuters

Diabetes drug may have cancer uses
UPI.com
2 (UPI) -- An ancient herbal remedy whose active ingredient is the main constituent of a modern diabetes drug may help combat cancer, two US studies show. ...
Diabetes drug may keep lung cancer at bayReuters
Diabetes drug might fight cancerScience News
Diabetes drug can reduce risk of cancer, researchers findLos Angeles Times
Softpedia -BusinessWeek -Medscape
all 221 news articles »


Cincinnati Business Courier

Grant aimed at better diabetes care in area
The Detroit News
A large percentage of Detroit and southeast Michigan residents have diabetes. "Information is the lifeblood of medicine," said Dr. David Blumenthal, ...
$16.2M grant aims to aid diabetic careDetroit Free Press
Cincinnati nonprofit to get $13.8M for health ITBusinessWeek
Metro Detroit gets $16.2 million grant for health information exchange on diabetesCrain's Detroit Business
Computerworld -ModernHealthcare.com -FierceEMR
all 61 news articles »


MSN India

Fish oil works against diabetes
Times of India
Obesity and diabetes are closely correlated. The scientists say omega-3 fatty acids activate this macrophage receptor, resulting in broad anti-inflammatory ...
Omega-3 fatty acids helps in fight against diabetesDiabetes.co.uk
Experts 'unlock' secret of fish oilThe Press Association
How Fish Oil Fights InflammationScience AAAS
Live in the Now -EurekAlert (press release) -TopNews United States
all 48 news articles »


Science Centric

60 Diabetes Seconds May Prevent A Diabetes Life
Huffington Post (blog)
Given the statistics, no matter where you live, no matter your age or race, fat or thin, you may get diabetes. Did you know type 2 diabetes is the fifth ...
The gold standard for tackling diabetesNorth Shore Times
Diabetes 'could become epidemic'BBC News
Optimizing Treatment for Type 1 DiabetesEmpowHer (blog)
Daily News & Analysis -WatertownDailyTimes.com -Los Angeles Times
all 37 news articles »


Modesto Bee

UCLA Study Finds Rising Levels of Obesity, Diabetes in California
California Healthline
Nearly 60% of California adults are overweight or obese and almost 8% of adult residents have diabetes, according to a recent report by the UCLA Center for ...
Stanislaus County struggles with worsening obesitySacramento Bee
LSUHSC pediatric weight expert provides obesity trinity answersEurekAlert (press release)
Read the new study, “Obesity and Diabetes: Two Growing Epidemics in California.”ScienceBlog.com (blog)
Daily Breeze -KPBS -UC Los Angeles
all 80 news articles »


Washington Post

If it can happen in the US, why not Canada?
Daily Gleaner
For instance, more than 250000 US veterans are getting compensation for diabetes, according to the records held by USVA. In fact, more Vietnam veterans are ...
Agent Orange cases may cost billions moreWashington Post
Vets' Agent Orange diabetes claims soarBoston Herald
Diabetes now tops Vietnam vets' claimsThe Associated Press
NewsBusters (blog) -Paris Post Intelligencer -Spartanburg Herald Journal
all 660 news articles »



Get Home Alerts
Huffington Post (blog)
The study, published in the September issue of The American Journal of Medicine, also shows that breastfeeding can help women avoid diabetes. ...



Eisai to Launch Rapid-acting Insulin Secretagogue Glufast(R) in China
MarketWatch (press release)
Eisai has focused its efforts in China on the development of the peripheral neuropathy treatment Methycobal(R) and other diabetes treatments such as -Lipon ...

and more »


New Diabetes Drug Shows Promise
Washington Informer
A new treatment for Type 2 diabetes has shown exceptional promise for helping African-Americans treat and manage the illness. In trials of Victoza, ...


Google News

home | site map
© 2006